Summit Therapeutics (SMMT) Other Gross PP&E Adjustments (2020 - 2025)
Historic Other Gross PP&E Adjustments for Summit Therapeutics (SMMT) over the last 6 years, with Q3 2025 value amounting to -$5.4 million.
- Summit Therapeutics' Other Gross PP&E Adjustments rose 3204.61% to -$5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.4 million, marking a year-over-year increase of 3204.61%. This contributed to the annual value of -$19.8 million for FY2024, which is 12620.98% down from last year.
- Per Summit Therapeutics' latest filing, its Other Gross PP&E Adjustments stood at -$5.4 million for Q3 2025, which was up 3204.61% from -$5.6 million recorded in Q2 2025.
- Summit Therapeutics' Other Gross PP&E Adjustments' 5-year high stood at -$1.5 million during Q1 2021, with a 5-year trough of -$19.8 million in Q4 2024.
- In the last 5 years, Summit Therapeutics' Other Gross PP&E Adjustments had a median value of -$5.6 million in 2025 and averaged -$5.9 million.
- As far as peak fluctuations go, Summit Therapeutics' Other Gross PP&E Adjustments crashed by 282180.45% in 2021, and later surged by 3630.11% in 2025.
- Quarter analysis of 5 years shows Summit Therapeutics' Other Gross PP&E Adjustments stood at -$3.6 million in 2021, then plummeted by 61.63% to -$5.9 million in 2022, then crashed by 49.39% to -$8.7 million in 2023, then plummeted by 126.21% to -$19.8 million in 2024, then surged by 72.59% to -$5.4 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$5.4 million for Q3 2025, versus -$5.6 million for Q2 2025 and -$6.4 million for Q1 2025.